{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:07:29Z","timestamp":1789715249273,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.neuropharm.2007.08.014","type":"journal-article","created":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T11:18:35Z","timestamp":1188299915000},"page":"832-841","source":"Crossref","is-referenced-by-count":41,"title":["Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats"],"prefix":"10.1016","volume":"53","author":[{"given":"Chun-Qing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Na","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2007.08.014_bib1","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1046\/j.1460-9568.2000.00267.x","article-title":"Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats","volume":"12","author":"Anichtchik","year":"2000","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/exnr.2000.7362","article-title":"An altered histaminergic innervation of the substantia nigra in Parkinson's disease","volume":"163","author":"Anichtchik","year":"2000","journal-title":"Experimental Neurology"},{"issue":"Pt\u00a03","key":"10.1016\/j.neuropharm.2007.08.014_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/brain\/115.3.825","article-title":"Behavioural analysis of unilateral monoamine depletion in the marmoset","volume":"115","author":"Annett","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0306-4522(95)00112-V","article-title":"Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat","volume":"67","author":"Barneoud","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.410310202","article-title":"Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?","volume":"31","author":"Beal","year":"1992","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0091-3057(98)00216-0","article-title":"Rotational behavior in dopamine nigrostriatal denervated rats: effects of a wide range of time intervals between apomorphine administrations","volume":"62","author":"Casas","year":"1999","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib7","first-page":"905","article-title":"Effect of histamine H3-receptor antagonist clobenpropit on spatial memory of radial maze performance in rats","volume":"21","author":"Chen","year":"2000","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib8","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/hmg\/ddi178","article-title":"Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection","volume":"14","author":"Chung","year":"2005","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib9","doi-asserted-by":"crossref","unstructured":"Coelho, M.H., Silva, I.J., Azevedo, M.S., and Manso, C.F., 1991. Decrease in blood histamine in drug-treated parkinsonian patients. Molecular and Chemical Neuropathology\/Sponsored by the International Society for Neurochemistry and the World Federation of Neurology and Research Groups on Neurochemistry and Cerebrospinal Fluid, 14, 77\u201385.","DOI":"10.1007\/BF03159928"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-2999(89)90071-X","article-title":"Cerebral histamine levels are unaffected by MPTP administration in the mouse","volume":"166","author":"Cumming","year":"1989","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1172\/JCI200317575","article-title":"Rare genetic mutations shed light on the pathogenesis of Parkinson disease","volume":"111","author":"Dawson","year":"2003","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway","volume":"175","author":"Deumens","year":"2002","journal-title":"Experimental Neurology"},{"issue":"Pt 5","key":"10.1016\/j.neuropharm.2007.08.014_bib13","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib14","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1523\/JNEUROSCI.22-03-00782.2002","article-title":"Distinct role for microglia in\u00a0rotenone-induced degeneration of dopaminergic neurons","volume":"22","author":"Gao","year":"2002","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbr.2004.03.007","article-title":"Intranigral injection of the H3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats","volume":"154","author":"Garcia-Ramirez","year":"2004","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/bss0660085","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"66","author":"Greenamyre","year":"1999","journal-title":"Biochemical Society Symposium"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nbd.2004.10.003","article-title":"Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism","volume":"18","author":"Greene","year":"2005","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib18","first-page":"121","article-title":"The role of histamine and the tuberomamillary nucleus in the nervous system. Nature reviews","volume":"4","author":"Haas","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0166-4328(02)00087-6","article-title":"Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat","volume":"139","author":"Henderson","year":"2003","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.neuroscience.2005.06.066","article-title":"Effects of carnosine on amygdaloid-kindled seizures in Sprague\u2013Dawley rats","volume":"135","author":"Jin","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbr.2005.07.014","article-title":"Effects of intracerebroventricular administration of ultra low doses of histaminergic drugs on morphine state-dependent memory of passive avoidance in mice","volume":"166","author":"Khalilzadeh","year":"2006","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib23","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000","article-title":"Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia","volume":"20","author":"Kim","year":"2000","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00242905","article-title":"Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression","volume":"108","author":"Labandeira-Garcia","year":"1996","journal-title":"Experimental Brain Research"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jnr.490380509","article-title":"Histamine-mediated neuronal death in a rat model of Wernicke's encephalopathy","volume":"38","author":"Langlais","year":"1994","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","article-title":"Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain","volume":"39","author":"Lawson","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/243521a0","article-title":"L-glutamic acid decarboxylase in Parkinson's disease: effect of L-dopa therapy","volume":"243","author":"Lloyd","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1471-4159.1975.tb04409.x","article-title":"Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and Parkinsonian patients","volume":"25","author":"Lloyd","year":"1975","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.08.024","article-title":"Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice","volume":"118","author":"Mobarakeh","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/syn.20270","article-title":"Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions","volume":"59","author":"Olds","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib32","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1073\/pnas.81.8.2572","article-title":"Histamine-containing neurons in the rat hypothalamus","volume":"81","author":"Panula","year":"1984","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib33","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1523\/JNEUROSCI.17-04-01377.1997","article-title":"AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochemical and in situ hybridization study","volume":"17","author":"Paquet","year":"1997","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib49","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib34","first-page":"343","article-title":"Histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid","volume":"33","author":"Prell","year":"1991","journal-title":"Agents and Actions Supplements"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4943(91)90002-8","article-title":"Influence of age and gender on the levels of histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid","volume":"12","author":"Prell","year":"1991","journal-title":"Archives of Gerontology and Geriatrics"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2007.08.014_bib36","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1002\/mds.870080507","article-title":"Nigral degeneration in Parkinson's disease","volume":"8","author":"Rinne","year":"1993","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib37","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1046\/j.1471-4159.2002.00871.x","article-title":"Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy","volume":"81","author":"Rinne","year":"2002","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","article-title":"Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease","volume":"275","author":"Scatton","year":"1983","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.10332","article-title":"Pathogenic role of glial cells in Parkinson's disease","volume":"18","author":"Teismann","year":"2003","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3959(94)90182-1","article-title":"Histamine-induced modulation of nociceptive responses","volume":"58","author":"Thoburn","year":"1994","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2005.11.026","article-title":"Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions","volume":"169","author":"Truong","year":"2006","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib44","first-page":"421","article-title":"Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons","volume":"5","author":"Ungerstedt","year":"1974","journal-title":"Advances in Neurology"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib45","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1471-4159.2000.0750540.x","article-title":"Histamine infusion induces a selective dopaminergic neuronal death along with an inflammatory reaction in rat substantia nigra","volume":"75","author":"Vizuete","year":"2000","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-8993(84)90811-4","article-title":"Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker","volume":"295","author":"Watanabe","year":"1984","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejphar.2003.09.066","article-title":"Effects of clobenpropit on pentylenetetrazole-kindled seizures in rats","volume":"482","author":"Zhang","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2007.08.014_bib48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1096\/fj.04-1586fje","article-title":"3-Hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity","volume":"19","author":"Zhang","year":"2004","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807002699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807002699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T16:59:20Z","timestamp":1556816360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390807002699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0028390807002699"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.08.014","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}